Genetika člověka
Mikrobiologické aplikace
NGS
Rapid testy
PCR plasty
Pipetovací špičky
Plasty pro buněčnou kultivaci
Systém pro dlouhodobé skladování vzorků
Zkumavky
Třepačky
Suché lázně
Centrifugy
End Point cyclery
Real-time PCR cyclery
Fluorometry
Spektrofotometry
Izolátory nukleových kyselin
Pipetovací roboty
Biobanking
Live Cell Imaging
Jednokanálové
Multikanálové
Sérologické pipety
Jednorázové pipety
Buněčné kultury
PCR, qPCR, RT
Detekce Mycoplasmat
Reverzní transkripce
Alergie
Intolerance
Elisa
Imunologické analyzátory
Veterinární imunologie
Alergie u zvířat
Intolerance u zvířat
Biochemie
Imunoanalýza
Human sLZIP Stably Over-Expressing PC3 Cell Line
| Unit |
1×10⁶ cells / 1.0 ml |
|---|---|
| Cell Type |
Stable (KO/Expressing) Cells |
| Tissue Type |
Prostate |
| Organism |
Human (H. sapiens) |
| Donor History |
Male ,62 ,White |
| Growth Properties |
Adherent ,epithelial |
| Growth Conditions |
PriCoat™ T25 Flasks (G299) or Applied Cell Extracellular Matrix (G422) are recommended for optimal cell culture. RPMI 1640 Medium (TM503) + 10% FBS + 1% Penicillin/Streptomycin Solution (G255) ,37.0°C ,5% CO₂. |
| Immortalization Method | |
| Full Information |
https://www.abmgood.com/Human-sLZIP-Stably-Over-Expressing-PC3-Cell-Line-T3455.html |
This PC3 cell line stably over-expresses small leucine zipper protein (sLZIP) – involved in various cellular functions, including transcription regulation, cell cycle progression, and apoptosis, which are critical in the study of cancer biology. This cell line may serve as an excellent model for prostrate cancer progression and metastasis. Over-expression of sLZIP in PC3 cells allows researchers to explore its effects on cancer cell behavior, including proliferation, migration, and response to therapeutic agents. This cell line is particularly useful for studies aimed at understanding the molecular mechanisms underpinning prostate cancer and developing targeted therapies. It is also beneficial for screening compounds that may modulate the function of sLZIP, potentially leading to new therapeutic approaches.
